FROM COMPLIANCE TO COMPETITIVE ADVANTAGE: WHAT CAA 2026 MEANS FOR YOUR PHARAMCY STRATEGY
PUBLISHED
June 18th, 2026
Anu Dhamecha, PHARMD and Chris Antypas, PHARMD
THE NEXT WAVE OF PHARMACY REGULATION IS HERE—AND IT’S MORE COMPLICATED THAN A COMPLIANCE EXERCISE. The Consolidated Appropriations Act of 2026 (CAA 2026) represents a meaningful shift in how pharmacy benefit managers (PBMs) are evaluated, monitored, and held accountable. While (…)
There’s more to Read